İvo Gökmen

7PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersPacific Peoples mothers and babies health and wellbeingCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
The CALLY Index Is Associated with Overall Survival in Patients with De Novo Metastatic Gastric Adenocarcinoma.

|Apr 14, 2026
Bevacizumab-Based Therapy Is Associated with Prolonged Progression-Free Survival in Patients with Peritoneal Mucinous Metastatic Colorectal Cancer.

Süleyman Can, Veli Çakıcı, Gizem Bakır Kahveci

|Feb 27, 2026
Medication Adherence in Women with Early-Stage Breast Cancer and Active Parenting Responsibilities: The Mediating Role of Parenting Stress and Spiritual Well-Being.

Veli Çakıcı, Aysel Oğuz, Süleyman Can

|Oct 06, 2025
Vismodegib treatment in locally advanced basal cell carcinoma limited to the facial region: a single-center experience.

İvo Gökmen, Erdem Şen

|Jul 07, 2025
Clinical Outcomes of CDK4/6 Inhibitor Therapy in HR+/HER2- Metastatic Breast Cancer: A Multicenter Comparison of HER2-Low and HER2-Zero Subgroups.

Erkan Ozcan, Ivo Gokmen, Fahri Akgul

|Feb 20, 2025
Prognostic Nutritional Index as a Biomarker in Metastatic Hormone-Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization.

Muhammet Bekir Hacioglu, Ahmet Kucukarda, Ivo Gokmen

Pageof 2

Frequent Collaborators

3 joint publications

Erkan Özcan

3 joint publications

Fahri Akgül

3 joint publications

Bülent Erdoğan

3 joint publications

Süleyman Can